Advertisement

Topics

Economics of PCSK9 Inhibitors

20:00 EDT 21 Aug 2017 | JAMA

This study uses the results of the FOURIER trial to assess the current cost-effectiveness of PCSK9 inhibitors over the lifetime analytic horizon for patients with atherosclerotic cardiovascular disease in the United States.

Original Article: Economics of PCSK9 Inhibitors

NEXT ARTICLE

More From BioPortfolio on "Economics of PCSK9 Inhibitors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...